| scholarly article | Q13442814 |
| P2093 | author name string | Janet L Davis | |
| Joyce C Schiffman | |||
| McGregor N Lott | |||
| P2860 | cites work | Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome | Q57768011 |
| INTRAVITREAL BEVACIZUMAB (AVASTIN) INJECTION AS PRIMARY TREATMENT OF INFLAMMATORY CHOROIDAL NEOVASCULARIZATION | Q57768021 | ||
| Punctate inner choroidopathy | Q58397561 | ||
| Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration | Q63384303 | ||
| Sympathetic ophthalmia and choroidal neovascularization. Case report | Q69046502 | ||
| Subfoveal and juxtafoveal Subretinal Neovascularization in the Presumed Ocular Histoplasmosis Syndrome | Q72380304 | ||
| Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization | Q73105558 | ||
| Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema | Q77156632 | ||
| Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin) | Q79547722 | ||
| Intravitreal bevacizumab for treatment of uveitic macular edema | Q79960243 | ||
| Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin | Q80217124 | ||
| Intravitreal bevacizumab for macular edema due to occlusive vasculitis | Q80469547 | ||
| Serpiginous choroiditis | Q81683999 | ||
| Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. | Q33223154 | ||
| Therapeutic efficacy of intravitreal bevacizumab on posterior uveitis complicated by neovascularization | Q34012249 | ||
| Medical treatment of cystoid macular edema | Q35174908 | ||
| Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression | Q35592899 | ||
| Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease | Q35761981 | ||
| Birdshot chorioretinopathy: long-term manifestations and visual prognosis | Q35762092 | ||
| Ocular complications of pediatric uveitis | Q35974718 | ||
| Inhibitors of ocular neovascularization: promises and potential problems. | Q36077697 | ||
| Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease. | Q36453871 | ||
| Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. | Q36805344 | ||
| Causes and frequency of blindness in patients with intraocular inflammatory disease | Q37319691 | ||
| Choroidal neovascularization associated with West Nile virus chorioretinitis. | Q40447352 | ||
| Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies | Q41607468 | ||
| Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults | Q44516148 | ||
| Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases | Q44615485 | ||
| Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography | Q44879359 | ||
| Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration | Q46484749 | ||
| Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study | Q46815448 | ||
| Somatostatin for Uveitic Cystoid Macular Edema (CME). | Q46830843 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bevacizumab | Q413299 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 711-717.e2 | |
| P577 | publication date | 2009-08-05 | |
| P1433 | published in | American Journal of Ophthalmology | Q4744258 |
| P1476 | title | Bevacizumab in inflammatory eye disease | |
| P478 | volume | 148 |
| Q37837267 | Added value of molecular targeted agents in oncology |
| Q58747622 | An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management |
| Q36407699 | Characterization of serous retinal detachments in uveitis patients with optical coherence tomography |
| Q37804876 | Clinical review: Update on treatment of inflammatory macular edema |
| Q36173230 | Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization |
| Q34786343 | Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis. |
| Q47551168 | Intravitreal bevacizumab for postviral fever retinitis: a novel approach for early resolution of macular oedema |
| Q50544506 | Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease. |
| Q58806282 | Intravitreal therapeutic agents in noninfectious uveitic macular edema |
| Q38215515 | Management of uveitis-related choroidal neovascularization: from the pathogenesis to the therapy. |
| Q55395409 | The effects of bevacizumab treatment in a rat model of retinal ischemia and perfusion injury. |
| Q34033983 | The effects of intravitreal bevacizumab in infectious and noninfectious uveitic macular edema |
| Q54641208 | [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014]. |
| Q84373475 | [Uveitis in juvenile idiopathic arthritis] |
Search more.